Hypogonadism Completed Phase 4 Trials for Liraglutide (DB06655)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03619330Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.Treatment